Chris Stenzel

Chris Stenzel serves as Vice President of Business Development and Innovation and Executive Managing Director of Kaiser Permanente Ventures, responsible for enhancing the organization's competitive edge through innovative business initiatives. With a background that includes leading the development of a successful corporate venture capital program with $500 million in investments, Chris has held roles such as CEO of Kaiser Permanente's wellness subsidiary and Senior Vice President of Venture Capital, M&A, and Corporate Development. Chris also contributes as a board member or observer for several healthcare companies, including Vesta Healthcare, Validic, and Health Transformation Alliance. Education includes a BA in Economics from UCLA and an MBA in Finance from the University of San Francisco.